全文获取类型
收费全文 | 508篇 |
免费 | 28篇 |
国内免费 | 1篇 |
出版年
2022年 | 5篇 |
2021年 | 11篇 |
2017年 | 3篇 |
2016年 | 23篇 |
2015年 | 29篇 |
2014年 | 19篇 |
2013年 | 27篇 |
2012年 | 31篇 |
2011年 | 34篇 |
2010年 | 10篇 |
2009年 | 10篇 |
2008年 | 17篇 |
2007年 | 22篇 |
2006年 | 26篇 |
2005年 | 18篇 |
2004年 | 24篇 |
2003年 | 19篇 |
2002年 | 26篇 |
2001年 | 15篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1998年 | 5篇 |
1993年 | 5篇 |
1992年 | 10篇 |
1990年 | 3篇 |
1988年 | 7篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1973年 | 2篇 |
1971年 | 4篇 |
1966年 | 2篇 |
1964年 | 2篇 |
1963年 | 9篇 |
1962年 | 10篇 |
1961年 | 3篇 |
1960年 | 2篇 |
1959年 | 3篇 |
1958年 | 4篇 |
1957年 | 3篇 |
1956年 | 3篇 |
1955年 | 5篇 |
1954年 | 5篇 |
1953年 | 4篇 |
1951年 | 4篇 |
1950年 | 2篇 |
1943年 | 5篇 |
1939年 | 2篇 |
1931年 | 2篇 |
排序方式: 共有537条查询结果,搜索用时 140 毫秒
1.
2.
Medical Research Council Working Party 《BMJ (Clinical research ed.)》1988,296(6636):1565-1570
Further analyses of the Medical Research Council''s trial of drug treatment of mild hypertension were carried out to provide more detailed information on the benefits associated with treatment in various subgroups. The four main considerations in establishing a rational treatment policy were, firstly, the significant reduction in the stroke rate with active treatment; secondly, the absence of a significant overall treatment effect on myocardial infarction; thirdly, the knowledge that of 100 untreated men in the highest risk group (those aged 55-64 with high systolic pressure at entry who smoked), five would be expected to suffer a stroke and 10 a coronary event within five years; and, fourthly, the cost, in clinical and financial terms, of prolonged treatment. In the high risk group of 100 men treatment with bendrofluazide would result in the prevention of three or four of the five strokes but would have little effect on the expected numbers of myocardial infarctions. Treatment with propranolol in non-smoking men in the highest age and blood pressure categories would lead to a reduction in the number having strokes from three to one or two and might possibly reduce the number experiencing myocardial infarction from seven to four. Smokers treated with propranolol would not be expected to benefit. In women avoiding smoking was particularly important. The considerations for preventing stroke were similar to those in men, but no clear guideline was possible on the effect of lowering blood pressure for preventing myocardial infarction in women.Drug treatment reduces the attack rate of certain events in mild hypertension but should not be prescribed routinely for all patients with the disorder. 相似文献
3.
4.
5.
6.
European Committee for Clinical Laboratory Standards Subcommittee on Reference Materials for Tissue Stains 《The Histochemical journal》1992,24(4):233-235
The names and affiliations of the SRMTS members are cited in Part I: terminology and general principles,Histochem. J. (1992)24, 217–19. 相似文献
7.
8.
G. J. van Steenbergen D. van Veghel D. N. Schulz M. Soliman-Hamad P. A. Tonino S. Houterman L. Dekker NHR THI Registration Committee 《Netherlands heart journal》2021,29(4):193
ObjectiveThe aim of this study is to assess the effects on procedural, 30-day, and 1‑year all-cause mortality by a newly introduced quality improvement strategy in patients after transcatheter aortic valve replacement (TAVR).MethodsIn October 2015, a coherent set of quality improving interventions with respect to patient geriatric screening, general diagnostic examination and safety of the procedure was implemented at a single centre in the Netherlands. Patients undergoing TAVR in 2013–2018 were included for retrospective analysis. Mortality was assessed in the pre-quality improvement strategy cohort (January 2013 to October 2015; cohort A) and in the post-quality improvement strategy cohort (November 2015 to December 2018; cohort B). Logistic regression analysis was used to estimate the influence of patient and procedural characteristics on the results of the quality improvement strategy in terms of procedural, 30-day, and 1‑year all-cause mortality.ResultsIn total, 806 patients were analysed with 274 patients in cohort A and 532 patients in cohort B. After introduction of the quality improvement strategy, procedural (4.4% to 1.3%, p < 0.01), 30-day (8.4% to 2.7%, p < 0.01) and 1‑year (16.4% to 8.5%, p < 0.01) all-cause mortality significantly decreased. Multivariate regression analysis showed that the quality improvement strategy also significantly reduced 30-day (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.09–0.42) and 1‑year (OR 0.38, 95% CI 0.24–0.61) all-cause mortality if corrected for patient characteristics.ConclusionStructural meetings on evaluation of outcomes highlight potential areas for improvement and subsequent outcome-based quality improvement initiatives can result in lower procedural, 30-day, and 1‑year all-cause mortality.Electronic supplementary materialThe online version of this article (10.1007/s12471-020-01526-7) contains supplementary material, which is available to authorized users. 相似文献
9.
Sponsored by Waters Corporation organized by the Education Committee: Dr. Kevin L. Knudtson Dr. Allis S. Chien Dr Natalia G. Reyero Vinas Dr LeRoy Martin Dr. Janet M Murray Dr. Paul A Rudnick Brian C. Searle Michael Zianni Tim C Hunter James Van Ee David Needleman Elke Kuster-Schock 《Journal of biomolecular techniques》2013,24(2):112
10.
Sumit Mohan Edwin Huff Jay Wish Michael Lilly Shu-Cheng Chen William M. McClellan for the Fistula First Breakthrough Initiative Data Committee 《PloS one》2013,8(12)